quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:39:54·1046d
PRRelease
Endo International plc logo

C3i partners with Paladin Labs Inc. to offer Canadian clinicians a complimentary testing service to detect T315I mutation

ENDP· Endo International plc
Health Care
Original source

Companies

  • ENDP
    Endo International plc
    Health Care

Recent analyst ratings

  • May 6UpdatePiper Sandler$1.00
  • Mar 9UpdateCitigroup$6.00
  • Mar 2UpdatePiper Sandler$3.00
  • Mar 2UpdateBarclays$2.00
  • Dec 16UpdateBarclays$5.00
  • Aug 31UpdatePiper Sandler$3.00

Related

  • PR1046d
    C3i partners with Paladin Labs Inc. to offer Canadian clinicians a complimentary testing service to detect T315I mutation
  • SEC1185d
    Endo International plc filed SEC Form 8-K: Other Events
  • SEC1210d
    Endo International plc filed SEC Form 8-K: Other Events
  • SEC1218d
    Endo International plc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
  • SEC1234d
    Endo International plc filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Material Impairments, Financial Statements and Exhibits
  • SEC1238d
    Endo International plc filed SEC Form 8-K: Other Events
  • SEC1261d
    SEC Form 10-Q filed by Endo International plc
  • SEC1261d
    Endo International plc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022